London ,United Kingdom - June 1, 2022 /NewsNetwork/ —
Accepted earlier in May 2022, featuring in the Value-Based Healthcare awards is one of many recognitions and accolades received by the company since it partnered with NHS Wales and Roche to create new software solutions through Reimburse. This includes awards like the House of Commons Award for Health IT Innovation in 2018 and its recognition as a Value-Based Healthcare Dragons Finalist in 2019 and 2020.
More details can be found at https://digipharm.io/reimburse
Digipharm’s recent award recognizes the company’s commitment to the development of efficiency-driven solutions for the healthcare industry.
A representative said, “Digipharm is pleased to announce that our blockchain technology and smart contracting collaboration project with Roche and NHS Wales was presented at the prestigious Value Based HealthCare Prize Awards. By implementing our Reimburse platform, both organisations will facilitate the world’s first value-based reimbursement agreement for a novel diagnostic test for heart failure. This will initially be within the Cwm Taf Morgannwg University Health Board.”
Reimburse is Digipharm’s flagship software solution that aims to create a platform where key stakeholders in the healthcare system can perform transactions using value-based agreements. The platform’s utility is multi-pronged, with benefits that apply to healthcare practitioners, manufacturers, vendors, and patients.
With Reimburse, healthcare service providers can tap into real-world analytics to qualify patient eligibility for services, develop value-based pricing systems, and implement secure pay-for-performance healthcare agreements.
Reimburse’s utility rests in its ability to automate the process involved in creating performance-based agreements using blockchain technology and smart contracting. This will also ensure data protection without opportunities for manipulation or tampering.
The platform will allow healthcare stakeholders to continue providing access to needed health technologies and interventions while maintaining strict control over their budgets.
About the Company
Digipharm develops innovative digital solutions for improving service delivery in health systems. The company has offices in London, England, and Basel, Switzerland. Aside from Reimburse, Digipharm also provides a wide range of healthcare services and products, including the Digihealth patient software application, which incentivizes patients to take part in clinical evaluations and other assessments.
For more information, please visit https://digipharm.io
Disclaimer: The information provided on this page does not constitute investment advice, financial advice, trading advice, or any other sort of advice and it should not be treated as such. This content is the opinion of a third party and this site does not recommend that any specific cryptocurrency should be bought, sold, or held, or that any crypto investment should be made. The Crypto market is high-risk, with high-risk and unproven projects. Readers should do their own research and consult a professional financial advisor before making any investment decisions.
Contact Info:
Name: Ahmed Abdulla
Email: Send Email
Organization: Digipharm Ltd
Address: 152-160 City Road, London , London EC1V 2NX, United Kingdom
Phone: +44-7838-770963
Website: https://digipharm.io/
Source: NewsNetwork
Release ID: 89076053
If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.
